Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00498-x)

Autor:	Combe, Bernard G., Tanaka, Yoshiya, Buch, Maya H., Nash, Peter, Burmester, Gerd R., Kivitz, Alan J., Bartok, Beatrix, Pechonkina, Alena, Xia, Katrina, Emoto, Kahaku, Kano, Shungo, Hendrikx, Thijs K., Landewé, Robert B. M., Aletaha, Daniel
Přispěvatelé:	Clinical Immunology and Rheumatology, AII - Inflammatory diseases
Jazyk:	angličtina
Rok vydání:	2023
Zdroj:	Rheumatology and therapy, 10(1), 71-72
ISSN:	2198-6576
Popis:	In this article the legend for Fig. 5 was inadvertently with error, the legend for Fig. 5 should have appeared as shown below.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=narcis______::5df95e89fb8e75082a1da9c045983545 https://pure.amc.nl/en/publications/correction(e4a92aaf-1e59-4bcf-a64e-840d8a4fb6ab).html Zobrazit plný text záznamu Full text from SpringerLink